149 related articles for article (PubMed ID: 38425352)
1. Neuro-mucormycosis: Lessons from COVID-19-associated cases.
Sedaghat N; Etemadifar M; Ghasemi P; Naghizadeh M; Mokari Y; Salari M; Golastani B
Curr J Neurol; 2023 Oct; 22(4):255-260. PubMed ID: 38425352
[No Abstract] [Full Text] [Related]
2. Rhino-orbito-cerebral mucormycosis: patient characteristics in pre-COVID-19 and COVID-19 period.
Cherian LM; Varghese L; Rupa V; Bright RR; Abraham L; Panicker R; R N; Peter J; Nayak A; Shyam A; Varghese GM; Manesh A; Karuppusami R; George K; George T; Lenin A; Hansdak SG; I R; Michael JS; Ninan M; Thomas M; Kurian R; Mammen S; Kurien R
Rhinology; 2022 Dec; 60(6):427-434. PubMed ID: 36150158
[TBL] [Abstract][Full Text] [Related]
3. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
[TBL] [Abstract][Full Text] [Related]
4. Hit or Miss: The Dilemma of Specimen Selection for Microbiological Diagnosis of Rhino-Orbital-Cerebral- COVID-Associated Mucormycosis (ROCM-CAM).
Jain V; Aggarwal A; Shrimali T; Vishwakarma K; Paul D; Kombade SP; Sharma V; Soni K; Choudhary B; Goyal A; Chugh A; Tiwari S; Sharma DK; Agarwal A; Misra S
Infect Disord Drug Targets; 2023; 23(1):e160822207524. PubMed ID: 35975857
[TBL] [Abstract][Full Text] [Related]
5. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
[TBL] [Abstract][Full Text] [Related]
6. Clinicoradiological profile and outcome of cavernous sinus syndrome with coronavirus disease-2019-associated rhino-orbito-cerebral mucormycosis.
Sulena S; Dhawan M; Singh N; Arora H; Singh G; Aggarwal V; Tapasvi C
J Neurosci Rural Pract; 2022; 13(4):730-739. PubMed ID: 36743739
[TBL] [Abstract][Full Text] [Related]
7. Uncontrolled diabetes mellitus exacerbated by COVID-19-induced inflammation is the risk factor for COVID-19-associated rhino-orbito-cerebral mucormycosis: A matched pair case-control study.
Karat S; Lobo AC; Satish D; Devaraj R; Manjooran RR; Nithyanandam S
Indian J Ophthalmol; 2022 Aug; 70(8):3096-3101. PubMed ID: 35918980
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis.
Watanabe A; So M; Mitaka H; Ishisaka Y; Takagi H; Inokuchi R; Iwagami M; Kuno T
Mycopathologia; 2022 Jun; 187(2-3):271-289. PubMed ID: 35312945
[TBL] [Abstract][Full Text] [Related]
9. COVID-associated rhinocerebral mucormycosis: a retrospective analysis of presentation and outcomes.
Moorthy A; Nayak T; Bachalli PS; Tripathi KK; Dutt SN; Kale P; Bhat P; Suresh PK; Gaikwad R; Raju A; Krishna S; Conjeevaram A; Mehta S; Anil-Kumar A; Haldipur D
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):713-721. PubMed ID: 35849188
[TBL] [Abstract][Full Text] [Related]
10. A clinico-pathological study of COVID-19 associated rhino-orbital-cerebral mucormycosis.
Mani S; Thirunavukkarasu A
Indian J Ophthalmol; 2022 Mar; 70(3):1013-1018. PubMed ID: 35225563
[TBL] [Abstract][Full Text] [Related]
11. Post-Covid Cerebral Mucormycosis, Varied Presentations and Surgical Strategies of a Newer Epidemic: An Institutional Experience.
Vijayasekhar MV; Nagappa V; Swaroop KH; Mithun G; Achuith E; Varaprasad KS
Neurol India; 2022; 70(3):1052-1056. PubMed ID: 35864638
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors of COVID-19 Associated Mucormycosis (CAM) in Iranian Patients: A Single-Center Retrospective Study.
Tavakolpour S; Irani S; Yekaninejad MS; Alimardi M; Hasibi M; Abdollahi H; Kazemi MA; Lotfi M; Shahbazian H; Nazemian Yazdi NA; Samimiardestani S; Firouzifar M; Farahbakhsh F; Mirzaee Goodarzi M; Feiz F; Salehinia F
Mycopathologia; 2022 Dec; 187(5-6):469-479. PubMed ID: 36202942
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-associated mucormycosis in India: Why such an outbreak?
Pasquier G
J Mycol Med; 2023 Aug; 33(3):101393. PubMed ID: 37182234
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary approach in diagnosis and treatment of COVID-19-associated mucormycosis: a description of current reports.
Gogineni H; So W; Mata K; Greene JN
Egypt J Intern Med; 2022; 34(1):58. PubMed ID: 35911783
[TBL] [Abstract][Full Text] [Related]
15. Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review.
Almyroudi MP; Akinosoglou K; Rello J; Blot S; Dimopoulos G
Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553099
[TBL] [Abstract][Full Text] [Related]
16. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.
Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S
J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299
[TBL] [Abstract][Full Text] [Related]
17. Sinonasal and Orbital Imaging Findings in COVID-Associated Rhino-Orbito-Cerebral Mucormycosis During the Second Wave of COVID-19: A Retrospective Cohort Study in a Tertiary Hospital in Central India.
B H S; Kumbhalkar S; Selvi K; G D; Bidkar V; Dabhekar S; Prathipati K; Sawal A
Cureus; 2023 Jul; 15(7):e42674. PubMed ID: 37649953
[TBL] [Abstract][Full Text] [Related]
18. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.
Karkhur S; Soni D; Chauhan K; Sarkar D; Gautam M; Verma S; Nyodu R; Yadav N; Sharma B
Indian J Ophthalmol; 2023 Jan; 71(1):39-56. PubMed ID: 36588206
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 associated rhino-orbito-cerebral mucormycosis, risk factors and outcome predictors; a multicentric study.
Rajabi MT; Aghajani A; Rafizadeh SM; Jamshidian Tehrani M; Poursayed Lazarjani SZ; Keshmirshekan MM; Mohammadi A; Akrami A; Parandin MM; Rajabi MB; Hosseini SS; Akbari M
Int Ophthalmol; 2023 Apr; 43(4):1375-1386. PubMed ID: 36209307
[TBL] [Abstract][Full Text] [Related]
20. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
Wasiq M; K R; Gn A
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
